| Overview |
| bs-2977R-RBITC |
| TAGL2 Polyclonal Antibody, RBITC Conjugated |
| FCM, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human, Mouse |
| Rat, Dog, Cow, Pig |
| Specifications |
| RBITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human TAGL2 |
| 51-160/199 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 8407 |
| P37802 |
| Cytoplasm, Secreted, Extracellular matrix |
| HA1756; Transgelin-2; Epididymis tissue protein Li 7e; SM22-alpha homolog; TAGLN2; KIAA0120; CDABP0035 |
| Calponin homology domain; actin-binding domain which may be present as a single copy or in tandem repeats (which increases binding affinity). The CH domain is found in cytoskeletal and signal transduction proteins, including actin-binding proteins. |
| Application Dilution |
| FCM |
1:20-100 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz